194 related articles for article (PubMed ID: 24876564)
1. Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.
Paiva B; Chandia M; Vidriales MB; Colado E; Caballero-Velázquez T; Escalante F; Garcia de Coca A; Montes MC; Garcia-Sanz R; Ocio EM; Mateos MV; San Miguel JF
Blood; 2014 Aug; 124(8):1300-3. PubMed ID: 24876564
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
4. Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands.
de Waal EG; Leene M; Veeger N; Vos HJ; Ong F; Smit WG; Hovenga S; Hoogendoorn M; Hogenes M; Beijert M; Diepstra A; Vellenga E
Br J Haematol; 2016 Nov; 175(4):661-667. PubMed ID: 27605358
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma.
Ghodke K; Shet T; Epari S; Sengar M; Menon H; Gujral S
Ann Diagn Pathol; 2015 Jun; 19(3):117-23. PubMed ID: 25842207
[TBL] [Abstract][Full Text] [Related]
6. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.
Kilciksiz S; Karakoyun-Celik O; Agaoglu FY; Haydaroglu A
ScientificWorldJournal; 2012; 2012():895765. PubMed ID: 22654647
[TBL] [Abstract][Full Text] [Related]
7. Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.
Fouquet G; Guidez S; Herbaux C; Van de Wyngaert Z; Bonnet S; Beauvais D; Demarquette H; Adib S; Hivert B; Wemeau M; Berthon C; Terriou L; Coiteux V; Macro M; Decaux O; Facon T; Huglo D; Leleu X
Clin Cancer Res; 2014 Jun; 20(12):3254-60. PubMed ID: 24714772
[TBL] [Abstract][Full Text] [Related]
8. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.
Shih LY; Dunn P; Leung WM; Chen WJ; Wang PN
Br J Cancer; 1995 Jan; 71(1):128-33. PubMed ID: 7819027
[TBL] [Abstract][Full Text] [Related]
9. Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis.
Hill QA; Rawstron AC; de Tute RM; Owen RG
Blood; 2014 Aug; 124(8):1296-9. PubMed ID: 24939658
[TBL] [Abstract][Full Text] [Related]
10. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
[TBL] [Abstract][Full Text] [Related]
12. Solitary plasmacytomas of bone and extramedullary plasmacytomas. A clinicopathologic and immunohistochemical study.
Meis JM; Butler JJ; Osborne BM; Ordóñez NG
Cancer; 1987 Apr; 59(8):1475-85. PubMed ID: 3102035
[TBL] [Abstract][Full Text] [Related]
13. Solitary plasmacytoma of bone: clinical features, treatment and survival.
Ellis PA; Colls BM
Hematol Oncol; 1992; 10(3-4):207-11. PubMed ID: 1398516
[TBL] [Abstract][Full Text] [Related]
14. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation and outcomes of solitary plasmacytoma in a tertiary hospital in the UK.
Agbuduwe C; Yang H; Gaglani J; Ajithkumar T
Clin Med (Lond); 2020 Sep; 20(5):e191-e195. PubMed ID: 32934063
[TBL] [Abstract][Full Text] [Related]
16. [Solitary plasmacytomas of bone and extramedullary plasmacytomas].
Yang D; Fan S; Tao H
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):41-4. PubMed ID: 8732111
[TBL] [Abstract][Full Text] [Related]
17. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
Galieni P; Cavo M; Avvisati G; Pulsoni A; Falbo R; Bonelli MA; Russo D; Petrucci MT; Bucalossi A; Tura S
Ann Oncol; 1995 Sep; 6(7):687-91. PubMed ID: 8664190
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of solitary extramedullary plasmacytoma.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
[TBL] [Abstract][Full Text] [Related]
19. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone.
Knowling MA; Harwood AR; Bergsagel DE
J Clin Oncol; 1983 Apr; 1(4):255-62. PubMed ID: 6668499
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience.
Alghisi A; Borghetti P; Maddalo M; Roccaro AM; Tucci A; Mazzola R; Magrini SM; Lo Casto A; Bonù ML; Tomasini D; Pasinetti N; Peretto G; Bertagna F; Tomasi C; Buglione M; Triggiani L
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1773-1779. PubMed ID: 33201300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
